971 related articles for article (PubMed ID: 19622536)
1. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
2. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluconazole consumption on long-term trends in candidal ecology.
Blot S; Janssens R; Claeys G; Hoste E; Buyle F; De Waele JJ; Peleman R; Vogelaers D; Vandewoude K
J Antimicrob Chemother; 2006 Aug; 58(2):474-7. PubMed ID: 16757503
[TBL] [Abstract][Full Text] [Related]
4. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
5. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
6. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
7. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial candidaemia in children: results of a 9-year study.
Celebi S; Hacimustafaoglu M; Ozdemir O; Ozkaya G
Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
[TBL] [Abstract][Full Text] [Related]
9. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Hope W; Morton A; Eisen DP
J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for candidaemia in critically ill patients: a prospective surveillance study.
Jordà-Marcos R; Alvarez-Lerma F; Jurado M; Palomar M; Nolla-Salas J; León MA; León C;
Mycoses; 2007 Jul; 50(4):302-10. PubMed ID: 17576324
[TBL] [Abstract][Full Text] [Related]
11. Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility.
Al-Sweih N; Khan Z; Khan S; Devarajan LV
Mycoses; 2009 Nov; 52(6):518-23. PubMed ID: 18983425
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
14. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
[TBL] [Abstract][Full Text] [Related]
15. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
16. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria.
Presterl E; Daxböck F; Graninger W; Willinger B
Clin Microbiol Infect; 2007 Nov; 13(11):1072-6. PubMed ID: 17725647
[TBL] [Abstract][Full Text] [Related]
17. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
Fridkin SK; Kaufman D; Edwards JR; Shetty S; Horan T
Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
20. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.
Dizbay M; Fidan I; Kalkanci A; Sari N; Yalcin B; Kustimur S; Arman D
Scand J Infect Dis; 2010; 42(2):114-20. PubMed ID: 19883150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]